Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 8
Submit an article Journal homepage
253
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Minimal residual disease detected by immunoglobulin sequencing predicts CLL relapse more effectively than flow cytometry

Andrew AwDivision of Hematology, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Canada; View further author information
,
Haesook T. KimDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; View further author information
,
Stacey M. FernandesDana-Farber Cancer Institute, Boston, MA, USA; View further author information
,
Kevin HoangDana-Farber Cancer Institute, Boston, MA, USA; View further author information
,
Siddha KasarDana-Farber Cancer Institute, Boston, MA, USA; View further author information
,
Malek FahamAdaptive Biotechnologies Corp, South San Francisco, CA, USA; View further author information
&
Jennifer R. BrownCLL Center and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
View further author information
 show all
Pages 1986-1989 | Received 10 Aug 2017, Accepted 15 Oct 2017, Published online: 22 Nov 2017
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Acknowledgements

We thank all the patients and their families who participated in this study and donated blood samples for analysis.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2017.1397664.

Additional information

Funding

This analysis was an investigator-initiated study designed by J.R.B. and funded by the Melton Family Fund for CLL Research, the Susan and Gary Rosenbach Fund for Lymphoma Research and American Cancer Society RSG-13-002-01-CCE.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.